Research workbench
Crystal structure of human 14-3-3 protein beta in complex with cftr peptide PS753PS768 and ppi stabilizer CY007424
Analyse Crystal structure of human 14-3-3 protein beta in complex with cftr peptide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 7QI1
- Type
- protein
- Length
- 973 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 14-3-3 protein BETA/ALPHA; Cystic fibrosis transmembrane conductance regulator
- EC
- 3.6.3.49
- UniProt
- S7N159, P13569
- Ligands
- ARG, Q95, TYR
- Pockets
- 9 · best druggability 0.76
Structure
x-ray diffraction · 6 distinct chains · 80% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 14-3-3 protein BETA/ALPHA | protein | 234 | 83% helix, 0% strand | S7N159 |
| B | 14-3-3 protein BETA/ALPHA | protein | 232 | 84% helix, 0% strand | S7N159 |
| F | Cystic fibrosis transmembrane conductance regulator (EC 3.6.3.49) | protein | 22 | 0% helix, 0% strand | P13569 |
| E | Cystic fibrosis transmembrane conductance regulator (EC 3.6.3.49) | protein | 16 | 0% helix, 6% strand | P13569 |
| C | 14-3-3 protein BETA/ALPHA | protein | 236 | 82% helix, 0% strand | S7N159 |
| D | 14-3-3 protein BETA/ALPHA | protein | 233 | 83% helix, 0% strand | S7N159 |
Ligands and binding sites
- ARG · Arginine · ligand · 2 copies · chains A, C, B
- Q95 · [2-(2-methylphenyl)sulfanylphenyl]methanamine · ligand · 2 copies · chains A, F, C, B
- TYR · Tyrosine · ligand · chains A, F, C
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1017 | 0.76 | 0.79 | 86 | ARG, Q95, TYR |
| 2 | 434 | 0.72 | 0.82 | 52 | empty |
| 3 | 764 | 0.70 | 0.77 | 59 | empty |
| 4 | 406 | 0.62 | 0.76 | 47 | empty |
| 5 | 201 | 0.49 | 0.75 | 28 | empty |
Interfaces
10 interfaces between chains.
- A–B · 1078 Ų buried · 11 hydrogen bonds · protein-protein
- C–D · 1027 Ų buried · 11 hydrogen bonds · protein-protein
- A–F · 998 Ų buried · 17 hydrogen bonds · protein-protein
- F–D · 830 Ų buried · 18 hydrogen bonds · protein-protein
- B–E · 773 Ų buried · 18 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 modified, 2 covalent (phosphorylation, covalent ligand).
Compared structures
- 7QI1 · Crystal structure of human 14-3-3 protein beta in complex with CFTR peptide pS753pS768… · the same entry in another collection · chain D against D, TM-score 1.00
- P13569 · AlphaFold monomer V2.0 prediction for cystic fibrosis transmembrane conductance regulator… · a predicted model of the same protein · chain E against A, TM-score 0.29
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt S7N159
- Every structure of UniProt P13569
- Elsewhere: RCSB PDB 7QI1 · PDBe 7QI1 · UniProt S7N159 · UniProt P13569
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.